Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 1998 Feb 1;101(3):515-20.
doi: 10.1172/JCI990.

Glucagon-like peptide 1 promotes satiety and suppresses energy intake in humans

A Flint  1 , A Raben, A Astrup, J J Holst
Affiliations
Clinical Trial

Glucagon-like peptide 1 promotes satiety and suppresses energy intake in humans

A Flint et al. J Clin Invest. .

Abstract

We examined the effect of intravenously infused glucagon-like peptide 1 (GLP-1) on subjective appetite sensations after an energy-fixed breakfast, and on spontaneous energy intake at an ad libitum lunch. 20 young, healthy, normal-weight men participated in a placebo-controlled, randomized, blinded, crossover study. Infusion (GLP-1, 50 pmol/ kg.h or saline) was started simultaneously with initiation of the test meals. Visual analogue scales were used to assess appetite sensations throughout the experiment and the palatability of the test meals. Blood was sampled throughout the day for analysis of plasma hormone and substrate levels. After the energy-fixed breakfast, GLP-1 infusion enhanced satiety and fullness compared with placebo (treatment effect: P < 0.03). Furthermore, spontaneous energy intake at the ad libitum lunch was reduced by 12% by GLP-1 infusion compared with saline (P = 0.002). Plasma GLP-1, insulin, glucagon, and blood glucose profiles were affected significantly by the treatment (P < 0.002). In conclusion, the results show that GLP-1 enhanced satiety and reduced energy intake and thus may play a physiological regulatory role in controlling appetite and energy intake in humans.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Scand J Gastroenterol. 1997 Jun;32(6):552-5 - PubMed
    1. Annu Rev Physiol. 1997;59:257-71 - PubMed
    1. Nat Med. 1996 Nov;2(11):1254-8 - PubMed
    1. Acta Endocrinol (Copenh). 1972 Jul;70(3):487-509 - PubMed
    1. Biochem J. 1982 Dec 1;207(3):381-8 - PubMed

Publication types

MeSH terms